Fulton Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,228
Closed -$335K 675
2025
Q1
$335K Sell
2,228
-1,400
-39% -$235K 0.01% 502
2024
Q4
$670K Buy
3,628
+232
+7% +$44.7K 0.03% 356
2024
Q3
$669K Buy
3,396
+91
+3% +$18.9K 0.03% 351
2024
Q2
$683K Buy
3,305
+157
+5% +$35.6K 0.03% 327
2024
Q1
$853K Buy
3,148
+40
+1% +$9.55K 0.04% 300
2023
Q4
$735K Buy
3,108
+193
+7% +$38K 0.03% 302
2023
Q3
$571K Buy
2,915
+333
+13% +$68.4K 0.03% 331
2023
Q2
$543K Buy
2,582
+127
+5% +$25.3K 0.03% 330
2023
Q1
$495K Buy
2,455
+387
+19% +$87.7K 0.03% 328
2022
Q4
$450K Sell
2,068
-470
-19% -$103K 0.03% 331
2022
Q3
$500K Buy
2,538
+247
+11% +$53.3K 0.03% 295
2022
Q2
$490K Buy
2,291
+341
+17% +$83.3K 0.03% 304
2022
Q1
$554K Buy
1,950
+197
+11% +$60.7K 0.03% 302
2021
Q4
$660K Buy
1,753
+285
+19% +$111K 0.03% 292
2021
Q3
$606K Buy
1,468
+110
+8% +$45.7K 0.03% 293
2021
Q2
$502K Sell
1,358
-9
-0.7% -$3K 0.02% 306
2021
Q1
$396K Buy
1,367
+353
+35% +$98.1K 0.02% 327
2020
Q4
$253K Buy
+1,014
New +$241K 0.01% 389

Other funds holding CRL